Clinical Trial Update: Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating AVE0657 for Cheyne-Stokes respiration in patients with heart failure and sleep apnea was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cheyne-stokes Respiration
• Heart Failure
• Sleep Apnea

Drugs mentioned

• AVE0657

Snippet

Sponsor: Sanofi | Conditions: Heart Failure, Sleep Apnea Syndromes | Phase 2 | Status: TERMINATED